Liang, Y., Zhang, Q., Liao, L., Ouyang, Q., Han, X., Wang, Y., Mo, Q., Wang, C., Wang, Y., Sun, J., Li, W., Zhong, J., Tian, F., Gao, J., Fu, F., Fan, Y., Rong, S., Zhu, X., Yin, Y. (2025). SHR-A1811 plus adebrelimab in unresectable or metastatic triple-negative breast cancer: Results from a phase 1b/2 expansion cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1103